CELL & GENE THERAPY INSIGHTS

Dec 2021. Vol 7 Issue 11

Dec 2021

FEATURING

Issue Spotlight: Cell therapy bioprocessing and automation
Report: Innovation Insights November 2021

Other articles
Webinars

Spotlight

Expert Insight

Considerations for the development of autologous CAR-T cell products

Alexander Davidson,
Gerardo Santiago Toledo,
Kostadinka Lilova,
Michael Merges,
Peter Jones
11 January 2022
Expert Insight

Innovator Insight

Enabling clinical grade manufacturing of gene-engineered NK cells

Nina Möker,
Rizwan Romee,
Evelyn Ullrich
5 January 2022
Innovator Insight

Improving allogeneic manufacturing workflows

Dr. Evan Zynda,
Dr. Aditi Singh
4 November 2021
Innovator Insight

Interview


Expert Roundtable

A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture

Lauren M Drouin,
Fabien Dorange,
Bryan Silvey,
Mark White,
Steven Pincus
13 December 2021
Expert Roundtable

FastFacts


Viewpoint

Driving CARs on the biomanufacturing road to clinical success

Chelsia Qiuxia Wang,
Andy Hee-Meng Tan
10 January 2022
Viewpoint

Translation and automation hurdles for cell therapies

Jenny A Prange,
Beatrix Rauch-Schmid
9 December 2021
Viewpoint

Report

Other articles

Editorial

Innovator Insight

Interview

FastFacts

Webinars

Automated cell expansion: Current technologies and trends

Automated cell expansion: Current technologies and trends

Gus Kilgore, PhD
Gus Kilgore, PhD, Global Marketing Manager, Terumo BCT
Dalip Sethi, PhD
Dalip Sethi, PhD, Director, Scientific Affairs, Terumo BCT
Kathie Schneider
Kathie Schneider, Director, Global Commercial Lead, Terumo BCT
9 November 2021
Webinar
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture

Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture

Kenneth Olsen, PhD
Kenneth Olsen, PhD, Senior R&D Scientist, Personalized Medicine Business Unit, Lonza
 Rachel Perret, PhD
Rachel Perret, PhD, Team Leader, CAR T-cell Research Program, Malaghan Institute of Medical Research
23 November 2021
Webinar
Enabling clinical grade manufacturing of gene-engineered NK cells

Enabling clinical grade manufacturing of gene-engineered NK cells

Nina Möker
Nina Möker, R&D Reagents Manager, Allogeneic Cell Therapy, Miltenyi Biotec
Prof. Dr. Evelyn Ullrich
Prof. Dr. Evelyn Ullrich, Arbeitsgruppe Zelluläre Immunologie, Universitätsklinikum, Frankfurt am Main (kgu.de)
Rizwan Romee, MD
Rizwan Romee, MD, Associate Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute
Volker Huppert
Volker Huppert, Chief Development Officer Glycostem Therapeutics
30 November 2021
Webinar
Developing stem cell therapies: expansion strategies and lessons learned

Developing stem cell therapies: expansion strategies and lessons learned

Shirley Mei, PhD, MSc
Shirley Mei, PhD, MSc, Investigator, OHRI
Lauralyn McIntyre, MD, MHSc, FRCPC
Lauralyn McIntyre, MD, MHSc, FRCPC, Senior Scientist, OHRI
Catherine Siler, PhD
Catherine Siler, PhD, Field Applications Scientist, Corning Life Sciences
8 December 2021
Webinar
Putting the patient first: New modalities of manufacturing for cell therapy through real-time process changes

Putting the patient first: New modalities of manufacturing for cell therapy through real-time process changes

Chelsea C. White III
Chelsea C. White III, Schneider National Chair of Transportation & Logistics, H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology
Professor Ben Wang
Professor Ben Wang, Gwaltney Chair in Manufacturing Systems, Executive Director, Georgia Institute of Technology
Dr. Kan Wang
Dr. Kan Wang, Senior Research Engineer, Georgia Tech Manufacturing Institute, Georgia Institute of Technology
9 December 2021
Webinar